PHAXIAM Therapeutics S.A. is a leading biopharmaceutical company focused on developing innovative therapies for the treatment of cancer and autoimmune diseases. With a strong pipeline of potential therapies and a commitment to research and development, PHAXIAM is poised to make a significant impact in the healthcare industry.
